Skip to main content
. 2017 Jun 30;17:344. doi: 10.1186/s12906-017-1845-6

Fig. 4.

Fig. 4

Serum (a) IL-2; (b) IL-12; (c) IL-18 and (d) IFN-γ level in liver of normal and Xeniji (0.1, 1 and 2 g/kg body weight) treated mice. *indicates a significant difference compared with the normal control group, p < 0.05